The Hartford Balanced Income Fund Class C (HBLCX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
14.21
+0.04 (0.28%)
Jun 3, 2025, 4:00 PM EDT
-0.07% (1Y)
Fund Assets | 13.45B |
Expense Ratio | 1.64% |
Min. Investment | $2,000 |
Turnover | n/a |
Dividend (ttm) | 0.89 |
Dividend Yield | 6.25% |
Dividend Growth | 136.43% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Mar 27, 2025 |
Previous Close | 14.17 |
YTD Return | 2.08% |
1-Year Return | 8.35% |
5-Year Return | 26.93% |
52-Week Low | 13.41 |
52-Week High | 15.06 |
Beta (5Y) | 0.56 |
Holdings | 1472 |
Inception Date | Jul 31, 2006 |
About HBLCX
The The Hartford Balanced Income Fund Class C (HBLCX) seeks to provide current income with growth of capital as a secondary objective. Under normal circumstances, the Fund will target an allocation of approximately 45% equity securities and 55% fixed income investments, with the allocation generally varying by no more than 5%.
Fund Family Hartford Funds C
Category Allocation--30% to 50% Equity
Stock Exchange NASDAQ
Ticker Symbol HBLCX
Share Class Class C
Index Russell 1000 Value TR
Performance
HBLCX had a total return of 8.35% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.72%.
Top 10 Holdings
11.69% of assetsName | Symbol | Weight |
---|---|---|
Usd | n/a | 2.22% |
ConocoPhillips | COP | 1.26% |
UnitedHealth Group Incorporated | UNH | 1.24% |
Johnson & Johnson | JNJ | 1.21% |
Bank of America Corporation | BAC | 1.18% |
JPMorgan Chase & Co. | JPM | 1.09% |
Gilead Sciences, Inc. | GILD | 0.90% |
Merck & Co., Inc. | MRK | 0.87% |
PACCAR Inc | PCAR | 0.86% |
American International Group, Inc. | AIG | 0.84% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 27, 2025 | $0.09846 | Mar 28, 2025 |
Dec 27, 2024 | $0.10705 | Dec 30, 2024 |
Dec 17, 2024 | $0.50283 | Dec 18, 2024 |
Sep 26, 2024 | $0.09291 | Sep 27, 2024 |
Jun 26, 2024 | $0.09004 | Jun 27, 2024 |
Mar 26, 2024 | $0.1018 | Mar 27, 2024 |